SWTX Overview
Upcoming Projects (SWTX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SWTX)
-
Digging into the launch of Springworks Therapeutics' Ogsiveo (nirogacestat) in adult patients with progressive desmoid tumors
Ticker: SWTX
Executed On: Sep 06, 2024 at 11:30 AM EDT -
Exploring Breakthroughs in NF1-PN Treatment: Insights from SpringWorks' Phase 2b ReNeu Trial of Mirdametinib
Ticker: SWTX
Executed On: Jun 12, 2024 at 01:30 PM EDT -
Discussing Mirdametinib, an investigational MEK inhibitor, in neurofibromatosis type 1 (NF1), and how it compares to selumetinib
Ticker: SWTX
Executed On: Feb 15, 2024 at 02:00 PM EST -
A Second Look: Digging into the positive results from the Phase 3 DeFi trial of Springworks Therapeutics' Nirogacestat in adult patients with progressive desmoid tumors.
Ticker: SWTX
Executed On: Mar 31, 2023 at 10:00 AM EDT -
Digging into the positive results from the Phase 3 DeFi trial of Springworks Therapeutics' Nirogacestat in adult patients with progressive desmoid tumors
Ticker: SWTX
Executed On: Mar 13, 2023 at 01:00 PM EDT -
A discussion of DREAMM-5 Study (low-dose Blenrep + nirogacestat) in r/r Multiple myeloma
Tickers: SWTX, GSK
Executed On: May 23, 2022 at 01:30 PM EDT
Expired Projects (SWTX)
-
Analyzing SpringWorks' Mirdametinib in Adult and Pediatric Patients with NF1-Associated Plexiform Neurofibromas
Ticker: SWTX
Execute By: Jan 31, 2022
Upcoming & Overdue Catalysts (SWTX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SWTX)
-
Jazz Pharmaceuticals (JAZZ) Acquires SpringWorks Therapeutics' (SWTX) FAAH Inhibitor Program for post-traumatic stress disorder
Tickers: JAZZ, SWTX
Announcement Date: Oct 26, 2020 -
BeiGene (BGNE) forms MapKure, LLC, a newly created entity that is jointly owned by BeiGene and SpringWorks
Ticker: SWTX
Announcement Date: Jun 18, 2019
